{"id":238932,"date":"2025-12-01T11:00:12","date_gmt":"2025-12-01T11:00:12","guid":{"rendered":"https:\/\/evertise.net\/?p=128824"},"modified":"2025-12-01T11:00:12","modified_gmt":"2025-12-01T11:00:12","slug":"doseology-announces-launch-of-corporate-communications-program","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/","title":{"rendered":"Doseology Announces Launch of Corporate Communications Program"},"content":{"rendered":"

\"\"<\/strong><\/p>\n


\nKelowna, BC \u2013 December 1, 2025<\/strong> \u2013 Doseology Sciences Inc.<\/strong> (CSE: <\/a>MOOD<\/strong><\/a> | PINK: <\/a>DOSEF<\/strong><\/a> | FSE: <\/a>VU70<\/strong><\/a>)(\u201cDoseology\u201d or the \u201cCompany\u201d) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company\u2019s long-term commercial and capital-markets strategy.<\/p>\n

The program includes a three (3) month engagement with Guerilla Capital, with an option to renew, along with a one (1) year digital media communications agreement with Maynard Communications Ltd. Both engagements will commence at management\u2019s discretion, with the intention to proceed in short order.<\/p>\n

Program Overview<\/strong><\/h4>\n

Doseology is implementing a disciplined investor-relations framework intended to:<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0\u00a0 broaden distribution of corporate updates,<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0\u00a0 increase visibility across retail and institutional investor channels,<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0\u00a0 support consistent disclosure standards, and<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0\u00a0 reinforce capital-markets readiness as the Company advances its oral stimulant platform.<\/p>\n

Governance and Disclosure Alignment<\/strong><\/h4>\n

Operating in a regulated environment requires structured communication and responsible governance. Doseology is aligning its operational progress\u2014including manufacturing oversight, commercialization planning, and regulatory engagement\u2014with enhanced reporting standards expected of a maturing public issuer. This program reflects the Company\u2019s commitment to strengthening its governance foundation and ensuring consistent, transparent communication with the market.<\/p>\n

Executive Commentary<\/strong><\/h4>\n

Chris Jackson, Chief Executive Officer<\/p>\n

\u201cHaving previously founded Qtrade, I\u2019ve seen firsthand how essential strong governance and disciplined communication are to a public company\u2019s long-term success. At Doseology, ensuring our disclosures are transparent, timely, and aligned with best practices is a core priority as we continue to strengthen our disclosure practices and advance our strategy.\u201d<\/p>\n

Commercialization & Market Trends<\/strong><\/h4>\n

Global consumer demand continues shifting toward cleaner, controlled oral delivery formats, with functional and stimulant pouch products gaining significant traction across major markets.<\/p>\n

Patrick Sills, Doseology Head of Commercialization, formerly with Joint Venture between Swedish Match AB and Philip Morris International Inc. (PMI)<\/p>\n

\u201cIn my experience under the JV SMPM International, I witnessed how quickly oral formats reshaped modern consumption and created a new ritual. With the global pouch market expected to exceed US$ 69.46 billion by 2032* and functional stimulant formats outpacing traditional energy categories, Doseology\u2019s next-generation stimulant platform is directly aligned with these high-growth trends and strategically positioned within this rapidly evolving category.\u201d<\/p>\n

*Persistence Market Research – Nicotine Pouches Market Size, Share & Future Trends, 2032<\/em><\/p>\n

\u00a0<\/em>Guerilla Capital Engagement<\/strong><\/h4>\n

Doseology has engaged Guerilla Capital to provide:<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 investor outreach and communication support,<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 engagement across digital investor communities and online platforms,<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 capital-markets advisory and messaging guidance, and<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 enhanced distribution of corporate updates to retail audiences.<\/p>\n

Term: 3 months (renewable at the Company\u2019s option) commencing on December 1, 2025 and ending on February 28, 2026.
\nCompensation: $30,000 CAD<\/p>\n

Ryan Yanch, Independent Investor and Principal of Guerilla Capital<\/p>\n

\u201cAs an investor and now on behalf of Guerilla Capital, we\u2019ve seen Doseology demonstrate a commitment to consistent communication and responsible reporting. Strengthening investor engagement is an important step forward as the Company continues executing on its strategy.\u201d<\/p>\n

Regulatory Disclosure:<\/strong><\/h4>\n

Guerilla Capital and\/or its principals currently hold securities of Doseology; this engagement is not at arm\u2019s length. Compensation is not tied to stock performance.<\/em><\/p>\n

The contact information for Guerilla Capital is 84 Watson\u2019 Lane, Dundas, ON L9H 1T3, T: 416-832-1874 and E: ryan@guerillacapital.io.<\/p>\n

Maynard Communications Ltd. Engagement<\/strong><\/h4>\n

Doseology has entered into a one-year agreement with Maynard Communications Ltd. to support:<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 digital advertising and content distribution,<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 amplification of corporate developments across Maynard investor channels,<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 enhanced retail visibility, and<\/p>\n

\u25cf\u00a0\u00a0\u00a0\u00a0 broader media exposure within capital markets.<\/p>\n

Term: 6 months (renewable at the Company\u2019s option) commencing on December 1, 2025 and ending on May 31, 2026.
\nCompensation: $200,000 CAD<\/p>\n

Regulatory Disclosure:<\/strong><\/h4>\n

Maynard Communications Ltd. and\/or its principals currently hold securities of Doseology; this engagement is not at arm\u2019s length. Compensation is not tied to stock performance.<\/em><\/p>\n

The contact information for Maynard Communications Ltd. is Blk A, 15\/F Hill, Fer Commercial Building. 65-67 Bonham East Sheung Wan Hong Kong, T: +001.44.656.6777 and E: info@maynardcom.com.<\/p>\n

Doseology is committed to keeping the market informed of its progress and believes that this enhanced communication strategy will contribute to building long-term value for its shareholders.<\/p>\n

About Doseology Sciences Inc. <\/strong>(CSE: <\/a>MOOD<\/strong><\/a> | PINK: <\/a>DOSEF<\/strong><\/a> | FSE: <\/a>VU70<\/strong><\/a>)<\/h4>\n

Doseology Sciences Inc. is a biotechnology-driven consumer products company developing IP-backed oral stimulant technologies designed for cleaner profiles, precise delivery, and performance-focused functionality. Anchored by a commitment to rigorous scientific research and advanced formulation technologies, Doseology is dedicated to leading the industry in creating breakthrough oral stimulant products with meaningful consumer benefits. Doseology is focused on building long-term enterprise value through innovation, regulatory alignment, and the commercialization of differentiated stimulant products.<\/p>\n

On behalf of the Board of Directors,
\n<\/strong>Chris Jackson
\nCEO, Director
\nDoseology Sciences Inc.<\/p>\n

For more information, please contact the Company at:
\nEmail:<\/strong> hello@doseology.com<\/a>
\nWebsite:<\/strong> www.doseology.com<\/a>
\nPhone: <\/strong>604.908.3095<\/p>\n

Forward Looking Statements<\/strong><\/p>\n

This press release contains statements that constitute \u201cforward\u2010looking information\u201d within the meaning of applicable securities laws. Forward\u2010looking information is often identified by the words \u201cmay,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect\u201d or similar expressions. Readers are cautioned that forward\u2010looking information is not based on historical facts but instead reflects the Company\u2019s management\u2019s expectations, estimates or projections concerning the business of the Company\u2019s future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward\u2010looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward\u2010looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; decreases in the prevailing prices for products in the markets that the Company operates in; adverse changes in applicable laws or adverse changes in the application or enforcement of current laws; regulations and enforcement priorities of governmental authorities; compliance with government regulation and related costs; and other risks described in the Company\u2019s prospectus. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward\u2010looking information prove incorrect, actual results may vary materially from<\/p>\n

those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward\u2010looking information except as otherwise required by applicable law. For more information, investors should review the Company\u2019s filings which are available on SEDAR+<\/a>.<\/p>\n

No securities regulatory authority has either approved or disapproved of the contents of this press release.<\/p>\n","protected":false},"excerpt":{"rendered":"

Kelowna, BC \u2013 December 1, 2025 \u2013 Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(\u201cDoseology\u201d or the \u201cCompany\u201d) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company\u2019s long-term commercial and capital-markets strategy. The program includes a three (3) [\u2026] Continue Reading →<\/span><\/a><\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[391,57,387,388],"tags":[],"class_list":["post-238932","post","type-post","status-publish","format-standard","hentry","category-internal","category-ips","category-si","category-vm"],"yoast_head":"\nDoseology Announces Launch of Corporate Communications Program - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Doseology Announces Launch of Corporate Communications Program - Business\" \/>\n<meta property=\"og:description\" content=\"Kelowna, BC \u2013 December 1, 2025 \u2013 Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(\u201cDoseology\u201d or the \u201cCompany\u201d) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company\u2019s long-term commercial and capital-markets strategy. The program includes a three (3) [\u2026] Continue Reading →\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-01T11:00:12+00:00\" \/>\n<meta name=\"author\" content=\"Evertise\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Evertise\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/\",\"name\":\"Doseology Announces Launch of Corporate Communications Program - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/11\/Picture1-2-150x100.png\",\"datePublished\":\"2025-12-01T11:00:12+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#primaryimage\",\"url\":\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/11\/Picture1-2-150x100.png\",\"contentUrl\":\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/11\/Picture1-2-150x100.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Doseology Announces Launch of Corporate Communications Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca\",\"name\":\"Evertise\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g\",\"caption\":\"Evertise\"},\"sameAs\":[\"http:\/\/evertise.net\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/evertise\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Doseology Announces Launch of Corporate Communications Program - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/","og_locale":"en_US","og_type":"article","og_title":"Doseology Announces Launch of Corporate Communications Program - Business","og_description":"Kelowna, BC \u2013 December 1, 2025 \u2013 Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(\u201cDoseology\u201d or the \u201cCompany\u201d) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company\u2019s long-term commercial and capital-markets strategy. The program includes a three (3) [\u2026] Continue Reading →","og_url":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/","og_site_name":"Business","article_published_time":"2025-12-01T11:00:12+00:00","author":"Evertise","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Evertise","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/","url":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/","name":"Doseology Announces Launch of Corporate Communications Program - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#primaryimage"},"thumbnailUrl":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/11\/Picture1-2-150x100.png","datePublished":"2025-12-01T11:00:12+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#primaryimage","url":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/11\/Picture1-2-150x100.png","contentUrl":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/11\/Picture1-2-150x100.png"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2025\/12\/01\/doseology-announces-launch-of-corporate-communications-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Doseology Announces Launch of Corporate Communications Program"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca","name":"Evertise","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g","caption":"Evertise"},"sameAs":["http:\/\/evertise.net"],"url":"https:\/\/ipsnews.net\/business\/author\/evertise\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/238932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=238932"}],"version-history":[{"count":2,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/238932\/revisions"}],"predecessor-version":[{"id":238971,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/238932\/revisions\/238971"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=238932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=238932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=238932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}